Evaluation of an ultra-low-dose oral contraceptive for dysmenorrhea: a placebo-controlled, double-blind, randomized trial
article
OA: closed
CC0
⤵ 6 in-corpus citations
Limited metadata. Only one source feed has indexed
this record so far — no abstract, full text, or open-access copy is
available through Endo Lab. The
publisher's page (linked below)
is the canonical location for the actual content. If you have institutional
access, use "Find at my library".
My notes (saved in your browser only)
Condition tags
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (23)
- A gonadotropin-releasing hormone agonist versus a continuous oral contraceptive pill in the treatment of bladder endometriosis via openalex
- A new oral contraceptive regimen for endometriosis management: preliminary experience with 24/4-day drospirenone/ethinilestradiol 3 mg/20 mcg via openalex
- Continuous low‐dose oral contraceptive in the treatment of colorectal endometriosis evaluated by rectal endoscopic ultrasonography via openalex
- Continuous use of an oral contraceptive for endometriosis-associated recurrent dysmenorrhea that does not respond to a cyclic pill regimen via openalex
- Dosage aspects of danazol therapy in endometriosis: Short-term and long-term effectiveness via openalex
- Dysmenorrhea and endometriosis in young women. via openalex
- Endometriosis via openalex
- Endometriosis: pathogenesis and treatment via openalex
- In women with endometriosis anti-Mullerian hormone levels are decreased only in those with previous endometrioma surgery via openalex
- Long-term oral contraceptive pills and postoperative pain management after laparoscopic excision of ovarian endometrioma: a randomized controlled trial via openalex
- Low-dose oral contraceptive pill for dysmenorrhea associated with endometriosis: a placebo-controlled, double-blind, randomized trial via openalex
- Post-operative endometriosis recurrence: a plea for prevention based on pathogenetic, epidemiological and clinical evidence via openalex
- Recurrence of endometrioma after laparoscopic excision and its prevention by medical management via openalex
- Reproductive performance, pain recurrence and disease relapse after conservative surgical treatment for endometriosis: the predictive value of the current classification system via openalex
- doi:10.1097/01.aog.0000230214.26638.0c via openalex
- doi:10.2147/ijwh.s70935 via openalex
- doi:10.1136/bmj.b2890 via openalex
- doi:10.1093/humupd/dmp007 via openalex
- doi:10.1111/j.1471-0528.1993.tb14309.x via openalex
- W6680857293 via openalex
- doi:10.1016/j.fertnstert.2011.02.045 via openalex
- doi:10.1016/0002-9378(82)90433-1 via openalex
- doi:10.1136/bmj.b2921 via openalex
Cited by (6)
- Assessing the impact of hormonal contraceptive use on menstrual health among women of reproductive age - a systematic review 2024
- Evaluation of the Characteristics of Ovarian Endometriomas in Patients with Endometriosis: Efficacy of a Low-Dose Estrogen/Progestogen Combination 2023
- Efficacy of Low-Dose Estrogen–Progestins and Progestins in Japanese Women with Dysmenorrhea: A Systematic Review and Network Meta-analysis 2022
- An assessment of the efficacy and safety of dydrogesterone in women with ovarian endometrioma: An open‐label multicenter clinical study 2021
- Long‐term use of dienogest for the treatment of primary and secondary dysmenorrhea 2020
- A multicenter, randomized, placebo-controlled, double-blind, comparative study of dienogest at 1 mg/day in patients with primary and secondary dysmenorrhea 2020
Source provenance
- openalex
- last seen: 2026-05-11T05:42:58.953575+00:00
License: CC0
· commercial use OK